Gene expression profiling in multiple sclerosis: A disease of the central nervous system, but with relapses triggered in the periphery?

Neurobiology of Disease

Volumn 37, Issue 3, 2010, Pages 613-621

  Brynedal, Boel ^a   Khademi, Mohsen ^b   Wallström, Erik ^b   Hillert, Jan ^a   Olsson, Tomas ^b   Duvefelt, Kristina ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Center for Molecular Medicine   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CSF; Gene expression profiling; Microarray; Multiple sclerosis; PBMC; Relapse

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RNA EXTRACTION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 75949086212     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.11.014     Document Type: Article

References (49)

1. Achiron A., et al. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann. N.Y. Acad. Sci. 1107 (2007) 155-167
2. Achiron A., and Gurevich M. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun. Rev. 5 (2006) 517-522
3. Arthur A.T., et al. Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med. Genet. 9 (2008) 17
4. Avasarala J.R., et al. Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2. BMC Med. Genomics 1 (2008) 2
5. Ban M., et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 17 (2009) 1309-1313
6. Benjamini Y., and Hochberg Y. Controlling the false disovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 57 (1995) 298-300
7. Bomprezzi R., et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 12 (2003) 2191-2199
8. Bright J.J., et al. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J. Immunol. 162 (1999) 6255-6262
9. Bruford E.A., et al. The HGNC Database in 2008: a resource for the human genome. Nucleic Acids Res. 36 (2008) D445-448
10. Brynedal B., et al. Differential expression, and genetic association, of CD58 in Swedish multiple sclerosis patients. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) E58 author reply E59
11. Cepok S., et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124 (2001) 2169-2176
12. Cloutier A., et al. Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors. J. Immunol. 182 (2009) 563-571
13. De Jager P.L., et al. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain 131 (2008) 1701-1711
14. De Jager P.L., et al. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 5264-5269
15. De Jager P.L., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41 (2009) 776-782
16. Durinck S., et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21 (2005) 3439-3440
17. Elkon R., et al. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res. 13 (2003) 773-780
18. Fossey S.C., et al. Identification of molecular biomarkers for multiple sclerosis. J. Mol. Diagn. 9 (2007) 197-204
19. Gentleman R.C., and Falcon S. Category: Category Analysis (2007)
20. Gentleman R.C., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5 (2004) R80
21. Jagodic M., et al. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci. Transl. Med. 1 (2009) 10ra21
22. Kanehisa M., and Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000) 27-30
23. Kanehisa M., et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34 (2006) D354-357
24. Kanehisa M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36 (2008) D480-D484
25. Kauffman M.A., et al. Whole genome analysis of the action of interferon-beta. Int. J. Clin. Pharmacol. Ther. 47 (2009) 328-357
26. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
27. Malmestrom C., et al. Relapses in multiple sclerosis are associated with increased CD8+T-cell mediated cytotoxicity in CSF. J. Neuroimmunol. 196 (2008) 159-165
28. Matys V., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34 (2006) D108-D110
29. McDonald W.I., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
30. Morey J.S., et al. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol. Proced. Online 8 (2006) 175-193
31. Mujtaba M.G., et al. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. J. Immunol. 175 (2005) 5077-5086
32. Muthian G., and Bright J.J. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J. Clin. Immunol. 24 (2004) 542-552
33. Natarajan C., and Bright J.J. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun. 3 (2002) 59-70
34. Natarajan C., et al. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia 45 (2004) 188-196
35. Öckinger J., et al. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun. (2009). http://doi:10.1038/gene.2009.82 doi:10.1038/gene.2009.82
36. Pruitt K.D., et al. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35 (2007) D61-65
37. R Development Core Team. R: A Language and Environment for Statistical Computing (2007), R Foundation for Statistical Computing, Vienna, Australia
38. Sarkijarvi S., et al. Gene expression profiles in Finnish twins with multiple sclerosis. BMC. Med. Genet. 7 (2006) 11
39. Satoh J., et al. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J. Neuroimmunol. 174 (2006) 108-118
40. Satoh J., et al. Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis. Dis. Markers. 25 (2008) 27-35
41. Schroeder A., et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 7 (2006) 3
42. Sellebjerg F., et al. Gene expression analysis of interferon-beta treatment in multiple sclerosis. Mult. Scler. 14 (2008) 615-621
43. Singh M.K., et al. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. J. Neurol. Sci. 258 (2007) 52-59
44. Stegmann A., et al. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol. Genomics 27 (2006) 141-155
45. Trivedi C.M., et al. Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis 195 (2007) e50-60
46. Wang C., et al. Mouse lysocardiolipin acyltransferase controls the development of hematopoietic and endothelial lineages during in vitro embryonic stem-cell differentiation. Blood 110 (2007) 3601-3609
47. Wilson C.L., and Miller C.J. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21 (2005) 3683-3685
48. Wingender E., et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28 (2000) 316-319
49. Wu Z., et al. A model-based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99 (2004) 909-917